Sai Parenterals Completes Acquisition of SP Analytics, Makes it Wholly Owned Subsidiary

Sai Parenterals Limited announced that its Board of Directors, in a meeting held on November 1, 2026, approved the un-audited financial results for the quarter and half-year ended September 30, 2026. The board also approved the acquisition of the remaining 25% equity shareholding in its subsidiary, SP Analytics Private Limited, for a cash consideration of ₹25,000, making SP Analytics a wholly owned subsidiary. Additionally, the company finalized the acquisition of 60% equity in Saicriti Pharma Private Limited, which also became a subsidiary. A Management Committee was also constituted.